OpenURL Connection Search

Select item for more details and to access through your institution.

Efficacy and safety of alirocumab among individuals with diabetes mellitus and atherosclerotic cardiovascular disease in the ODYSSEY phase 3 trials.
Published in:
Diabetes, Obesity & Metabolism, 2018, v. 20, n. 10, p. 2389, doi. 10.1111/dom.13384
By:
- Ganda, Om P.;
- Plutzky, Jorge;
- Sanganalmath, Santosh K.;
- Bujas‐bobanovic, Maja;
- Koren, Andrew;
- Mandel, Jonas;
- Letierce, Alexia;
- Leiter, Lawrence A.
Publication type:
Article
Dronedarone treatment following cardioversion in patients with atrial fibrillation/flutter: A post hoc analysis of the EURIDIS and ADONIS trials.
Published in:
Journal of Cardiovascular Electrophysiology, 2020, v. 31, n. 5, p. 1022, doi. 10.1111/jce.14405
By:
- Thind, Munveer;
- Crijns, Harry J.;
- Naccarelli, Gerald V.;
- Reiffel, James A.;
- Corp dit Genti, Valérie;
- Wieloch, Mattias;
- Koren, Andrew;
- Kowey, Peter R.
Publication type:
Article
Development and Content Validity of the Statin Experience Assessment Questionnaire (SEAQ)©.
Published in:
Patient, 2017, v. 10, n. 3, p. 321, doi. 10.1007/s40271-016-0211-y
By:
- Jacobson, Terry;
- Edelman, Steven;
- Galipeau, Nina;
- Shields, Alan;
- Mallya, Usha;
- Koren, Andrew;
- Davidson, Michael
Publication type:
Article
A placebo-controlled comparison of the effects of doxazosin GITS 4mg and doxazosin standard 1mg on blood pressure and heart rate
Published in:
2005
By:
- Meredith, Peter A.;
- Koren, Andrew
Publication type:
Abstract
Left ventricular mass change during treatment and outcome in patients with essential hypertension.
Published in:
American Journal of Hypertension, 2002, v. 15, n. 12, p. 1021, doi. 10.1016/S0895-7061(02)03061-3
By:
- Koren, Michael J.;
- Ulin, Roy J.;
- Koren, Andrew T.;
- Laragh, John H.;
- Devereux, Richard B.
Publication type:
Article
Discordant responses of plasma low-density lipoprotein cholesterol and lipoprotein(a) to alirocumab: A pooled analysis from 10 ODYSSEY Phase 3 studies.
Published in:
European Journal of Preventive Cardiology, 2021, v. 28, n. 8, p. 816, doi. 10.1177/2047487320915803
By:
- Mahmood, Tahir;
- Minnier, Jessica;
- Ito, Matthew K.;
- Li, Qian H.;
- Koren, Andrew;
- Kam, Ivy W.;
- Fazio, Sergio;
- Shapiro, Michael D.
Publication type:
Article
Controlled-Release Doxazosin as Combination Therapy in Hypertension: The GATES Study.
Published in:
Journal of Clinical Hypertension, 2006, v. 8, n. 3, p. 159, doi. 10.1111/j.1524-6175.2006.04811.x
By:
- Black, Henry R.;
- Keck, Michael;
- Meredith, Peter;
- Bullen, Kevin;
- Quinn, Sheila;
- Koren, Andrew
Publication type:
Article
Efficacy and safety of dronedarone by atrial fibrillation history duration: Insights from the ATHENA study.
Published in:
Clinical Cardiology, 2020, v. 43, n. 12, p. 1469, doi. 10.1002/clc.23463
By:
- Blomström‐Lundqvist, Carina;
- Marrouche, Nassir;
- Connolly, Stuart;
- Corp dit Genti, Valérie;
- Wieloch, Mattias;
- Koren, Andrew;
- Hohnloser, Stefan H.
Publication type:
Article
Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation/flutter: Insights from the ATHENA study.
Published in:
Clinical Cardiology, 2020, v. 43, n. 3, p. 291, doi. 10.1002/clc.23309
By:
- Vamos, Mate;
- Calkins, Hugh;
- Kowey, Peter R.;
- Torp‐Pedersen, Christian T.;
- Corp dit Genti, Valérie;
- Wieloch, Mattias;
- Koren, Andrew;
- Hohnloser, Stefan H.
Publication type:
Article
Comparative Safety and Effectiveness of Sotalol Versus Dronedarone After Catheter Ablation for Atrial Fibrillation.
Published in:
2022
By:
- Wharton, John Marcus;
- Piccini, Jonathan P.;
- Koren, Andrew;
- Huse, Samuel;
- Ronk, Christopher J.
Publication type:
journal article
US Antiarrhythmic Drug Treatment for Patients With Atrial Fibrillation: An Insurance Claims-Based Report.
Published in:
2021
By:
- Tardos, Jonathan G.;
- Ronk, Christopher J.;
- Patel, Miraj Y.;
- Koren, Andrew;
- Kim, Michael H.
Publication type:
journal article
Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry.
Published in:
2019
By:
- Ying Xian;
- Navar, Ann Marie;
- Shuang Li;
- Zhuokai Li;
- Robinson, Jennifer;
- Virani, Salim S.;
- Louie, Michael J.;
- Koren, Andrew;
- Goldberg, Anne;
- Roger, Veronique L.;
- Wilson, Peter W. F.;
- Peterson, Eric D.;
- Wang, Tracy Y.;
- Xian, Ying;
- Li, Shuang;
- Li, Zhuokai
Publication type:
journal article
Budget Impact Analysis of PCSK9 Inhibitors for the Management of Adult Patients with Heterozygous Familial Hypercholesterolemia or Clinical Atherosclerotic Cardiovascular Disease.
Published in:
2018
By:
- Mallya, Usha;
- Koren, Andrew;
- Boklage, Susan;
- Delea, Thomas;
- Mullins, C.;
- Mallya, Usha G;
- Boklage, Susan H;
- Delea, Thomas E;
- Mullins, C Daniel
Publication type:
journal article
Comment on 'Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety'.
Published in:
2021
By:
- Koren, Andrew;
- Karas, Andreas;
- Echols, Roger
Publication type:
Letter
Erratum to: A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers.
Published in:
2015
By:
- Ezekowitz, Michael;
- Ellenbogen, Kenneth;
- DiMarco, John;
- Kaszala, Karoly;
- Boddy, Alexander;
- Geba, Gregory;
- Koren, Andrew
Publication type:
Erratum
A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers.
Published in:
Journal of Interventional Cardiac Electrophysiology, 2015, v. 42, n. 2, p. 69, doi. 10.1007/s10840-014-9966-z
By:
- Ezekowitz, Michael;
- Ellenbogen, Kenneth;
- DiMarco, John;
- Kaszala, Karoly;
- Boddy, Alexander;
- P., Gregory;
- Koren, Andrew
Publication type:
Article
Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia.
Published in:
Cardiovascular Drugs & Therapy, 2019, v. 33, n. 1, p. 69, doi. 10.1007/s10557-019-06852-6
By:
- Ginsberg, Henry N.;
- Tuomilehto, Jaakko;
- Hovingh, G. Kees;
- Cariou, Bertrand;
- Santos, Raul D.;
- Brown, Alan S.;
- Sanganalmath, Santosh K.;
- Koren, Andrew;
- Thompson, Desmond;
- Raal, Frederick J.
Publication type:
Article
A common data model to assess cardiovascular hospitalization and mortality in atrial fibrillation patients using administrative claims and medical records.
Published in:
Clinical Epidemiology, 2015, v. 7, p. 77, doi. 10.2147/CLEP.S64936
By:
- Panaccio, Mary P.;
- Cummins, Gordon;
- Wentworth, Charles;
- Lanes, Stephan;
- Reynolds, Shannon L.;
- Reynolds, Matthew W.;
- Miao, Raymond;
- Koren, Andrew
Publication type:
Article
Impact of Dronedarone Treatment on Healthcare Resource Utilization in Patients with Atrial Fibrillation/Flutter.
Published in:
Advances in Therapy, 2014, v. 31, n. 3, p. 318, doi. 10.1007/s12325-014-0108-x
By:
- Kim, Michael;
- Lin, Jay;
- Jhaveri, Mehul;
- Koren, Andrew
Publication type:
Article

Found: 19